XML 16 R4.htm IDEA: XBRL DOCUMENT v3.10.0.1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (Unaudited) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2018
Jun. 30, 2017
Jun. 30, 2018
Jun. 30, 2017
Revenues        
Research and development $ 2,661,216 $ 4,264,561 $ 4,409,150 $ 9,466,347
Operating expenses        
Selling, general and administrative 2,880,394 3,058,244 5,936,940 5,928,113
Research and development 3,312,181 5,067,838 6,320,007 11,428,327
Patent expenses 178,332 197,017 396,805 437,615
Total operating expenses 6,370,907 8,323,099 12,653,752 17,794,055
Operating loss (3,709,691) (4,058,538) (8,244,602) (8,327,708)
Decrease In Fair Value Of Warrants 360,285 294,356 (2,942,829) (331,853)
Interest expense (3,843,161) (3,652,496) (7,591,979) (7,261,412)
Gain (loss) from change in fair value of warrant liability (400,000) (300,000) (2,942,829) (331,853)
Other income, net 144,152 8,066 146,387 12,484
Loss before income taxes (7,048,415) (7,408,612) (18,633,023) (15,908,489)
Current Income Tax Expense (Benefit) (2,849)   (497)  
Provision for income taxes   (92,825)   (207,895)
Net and comprehensive loss $ (7,051,264) $ (7,501,437) $ (18,633,520) $ (16,116,384)
Loss per share: basic and diluted $ (0.09) $ (0.10) $ (0.24) $ (0.20)
Weighted average shares outstanding: basic and diluted 79,094,230 78,840,312 79,066,768 78,808,903